Agnieszka Chodala-Grzywacz
Overview
Explore the profile of Agnieszka Chodala-Grzywacz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Front Pediatr
. 2024 Nov;
12:1482720.
PMID: 39483533
Background: A personalised approach to the treatment of acute myeloid leukemia (AML) in children and adolescents, as well as the development of supportive therapies, has significantly improved survival. Despite this,...
2.
Fraczkiewicz J, Pawinska-Wasikowska K, Szymbor K, Balwierz W, Skoczen S, Czyzewski K, et al.
J Clin Med
. 2024 Apr;
13(7).
PMID: 38610794
Patients treated with hemato-oncological malignancies (HO) or undergoing cellular therapies such as hematopoietic stem cell transplantation (HSCT) or chimeric antigen receptor T cells (CAR-T) were significantly affected by severe acute...
3.
Pawinska-Wasikowska K, Czogala M, Bukowska-Strakova K, Surman M, Rygielska M, Ksiazek T, et al.
Cancers (Basel)
. 2024 Mar;
16(6).
PMID: 38539480
Background: The reports of studies that compare the survival of adolescents and young adults with younger children with acute myeloid leukemia (AML) are contradictory. Patients And Methods: We retrospectively analyzed...
4.
Samborska M, Skalska-Sadowska J, Achkar R, Wachowiak J, Derwich K, Czogala M, et al.
Contemp Oncol (Pozn)
. 2024 Feb;
27(4):249-254.
PMID: 38405205
Introduction: This study aimed to present the clinical features and results of treatment of patients diagnosed with refractory or relapsed acute myeloid leukaemia (AML) in Polish Paediatric Leukaemia/Lymphoma Study Group...
5.
Czogala M, Czogala W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Sikorska-Fic B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760526
Background: The FMS-like tyrosine kinase 3 (FLT3) gene mutated in 10-15% of pediatric acute myeloid leukemia (AML) is associated with an inferior outcome. The aim of the study was to...
6.
Czogala M, Rogatko I, Pawinska-Wasikowska K, Czogala W, Bal W, Ciebiera M, et al.
Contemp Oncol (Pozn)
. 2023 Feb;
26(4):282-288.
PMID: 36816392
Introduction: The aim of the study was to analyse the frequency of silent inactivation and allergic reaction to asparaginase (ASP) and its impact on treatment results in patients with lymphoblastic...
7.
Czogala M, Czogala W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Sikorska-Fic B, et al.
Cancers (Basel)
. 2023 Feb;
15(3).
PMID: 36765692
Acute P./myeloid leukemia post cytotoxic therapy (AML-pCT) is rare complication of cancer treatment in childhood. The objective of the study was to identify clinical characteristics and provide an analysis of...
8.
Samborska M, Baranska M, Wachowiak J, Skalska-Sadowska J, Thambyrajah S, Czogala M, et al.
Front Oncol
. 2022 Jul;
12:935373.
PMID: 35875115
Introduction: Myeloid sarcoma (MS) is an extramedullary malignant tumor composed of immature myeloid cells. It occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia...
9.
Czogala M, Balwierz W, Pawinska-Wasikowska K, Ksiazek T, Bukowska-Strakova K, Czogala W, et al.
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572762
Background: From 1983, standardized therapeutic protocols for pediatric acute myeloid leukemia (AML) based on the BFM group experience were introduced in Poland. We retrospectively analyzed the results of pediatric AML...
10.
Czogala M, Pawinska-Wasikowska K, Ksiazek T, Sikorska-Fic B, Matysiak M, Skalska-Sadowska J, et al.
Front Pediatr
. 2020 Jul;
8:277.
PMID: 32637384
Children with Down syndrome (DS) have increased risk of myeloid leukemia (ML), but specific treatment protocols ensure excellent outcome. This study was a retrospective analysis of the treatment results and...